4-Amino cyclohexylglycine analogues as potent dipeptidyl peptidase IV inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 1, 2004, Pages 43-46

  Parmee, Emma R ^a   He, Jiafang ^a   Mastracchio, Anthony ^a   Edmondson, Scott D ^a   Colwell, Larry ^a   Eiermann, George ^a   Feeney, William P ^a   Habulihaz, Bahanu ^a   He, Huaibing ^a   Kilburn, Ruth ^a   Leiting, Barbara ^a   Lyons, Kathryn ^a   Marsilio, Frank ^a   Patel, Reshma A ^a   Petrov, Aleksandr ^a   Di Salvo, Jerry ^a   Wu, Joseph K ^a   Thornberry, Nancy A ^a   Weber, Ann E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHYLAMIDE; 2,4 DIFLUOROBENZENESULFONAMIDE; AMIDE; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DISULFONAMIDE; ENZYME INHIBITOR; GLYCINE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; SUBSTITUTION REACTION;

EID: 0346252638     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.10.016     Document Type: Article

References (28)

1. (a) For lead references, see: Augustyns K., der Veken P.V., Senten K., Haemers A. Expert Opin. Ther. Pat. 13:2003;499 (b) Drucker D.J. Expert Opin. Invest. Drugs. 12:2003;87 (c) Holst J.J., Deacon D.F. Diabetes. 47:1998;1663 (d) Augustyns K., Bai G., Thonus G., Belyaev A., Zhang X.M., Bollaert W., Lambeir A.M., Durinx C., Goossens F., Haemers A. Curr. Med. Chem. 6:1999;311.
2. (a) For lead references, see: Augustyns K., der Veken P.V., Senten K., Haemers A. Expert Opin. Ther. Pat. 13:2003;499 (b) Drucker D.J. Expert Opin. Invest. Drugs. 12:2003;87 (c) Holst J.J., Deacon D.F. Diabetes. 47:1998;1663 (d) Augustyns K., Bai G., Thonus G., Belyaev A., Zhang X.M., Bollaert W., Lambeir A.M., Durinx C., Goossens F., Haemers A. Curr. Med. Chem. 6:1999;311.
3. (a) For lead references, see: Augustyns K., der Veken P.V., Senten K., Haemers A. Expert Opin. Ther. Pat. 13:2003;499 (b) Drucker D.J. Expert Opin. Invest. Drugs. 12:2003;87 (c) Holst J.J., Deacon D.F. Diabetes. 47:1998;1663 (d) Augustyns K., Bai G., Thonus G., Belyaev A., Zhang X.M., Bollaert W., Lambeir A.M., Durinx C., Goossens F., Haemers A. Curr. Med. Chem. 6:1999;311.
4. (a) For lead references, see: Augustyns K., der Veken P.V., Senten K., Haemers A. Expert Opin. Ther. Pat. 13:2003;499 (b) Drucker D.J. Expert Opin. Invest. Drugs. 12:2003;87 (c) Holst J.J., Deacon D.F. Diabetes. 47:1998;1663 (d) Augustyns K., Bai G., Thonus G., Belyaev A., Zhang X.M., Bollaert W., Lambeir A.M., Durinx C., Goossens F., Haemers A. Curr. Med. Chem. 6:1999;311.
5. (a) Ahren B., Larsson J., Holst J.J. J. Clin. Endocrinol. Metab. 82:1997;473
6. (b) Rachman J., Borrow B.A., Levy J.C., Turner R.C. Diabetologia. 40:1997;205
7. (c) Nauck M.A., Wollschlager D., Werner J., Holst J.J., Orskov C., Creutzeldt W., Willms B. Diabetologia. 39:1996;1546
8. (d) Drucker D.J. Gastroenterology. 122:2002;531.
9. Zander M., Madsbad S., Madsen J.L., Holst J.J. Lancet. 359:2002;824.
10. (a) Marguet D., Baggio L., Kobayashi T., Bernard A.-M., Pierres M., Nielsen P.F., Ribel U., Watanabe T., Drucker D.J., Wagtmann N. Proc. Natl. Acad. Sci. U.S.A. 97:2000;6864
11. (b) Conarello S.L., Li Z., Ronan J., Sinha Roy R., Zhu L., Jiang G., Liu F., Woods J., Zycband E., Thornberry N.A., Zhang B.B. Proc. Natl. Acad. Sci. U.S.A. 100:2003;6825.
12. (a) Reimer M.K., Holst J.J., Ahren B. Eur. J. Endocrin. 146:2002;717
13. (b) Pospisilik J.A., Martin J., Doty T., Ehses J.A., Pamir N., Lynn F.C., Piteau S., Demuth H.-U., McIntosh C.H.S., Pederson R.A. Diabetes. 52:2003;741.
14. (a) Ahren B., Simonsson E., Larsson H., Landin-Olsson M., Torgeirsson H., Jansson P.-A., Sandqvist M., Bavenholm P., Efendic S., Eriksson J.W., Dickinson S., Holmes D. Diabetes Care. 25:2002;869
15. (b) Ahren B., Landin-Olsson M., Jansson P.-A., Eriksson J., Pacini G., Tomaseth K., Schweizer A. Diabetes. 52(Supp. 11):2003;A15.
16. Sorbera L.A., Revel L., Castaner J. Drugs Future. 26:2001;859.
17. For assay conditions for DP-IV and QPP inhibition, see: Leiting B., Pryor K.D., Wu J.K., Marsilio F., Patel R.A., Craik C.S., Ellman J.A., Cummings R.T., Thornberry N.A. Biochem. J. 371:2003;525.
18. (a) Villhauer E.B., Brinkman J.A., Naderi G.B., Burkey B.F., Dunning B.E., Prasad K., Mangold B.L., Russell M.E., Hughes T.E. J. Med. Chem. 46:2003;2774
19. (b) Villhauer E.B., Brinkman J.A., Naderi G.B., Dunning B.E., Mangold B.L., Mone M.D., Russell M.E., Weldon S.C., Hughes T.E. J. Med. Chem. 45:2002;2362.
20. Ashworth D.M., Atrash B., Baker G.R., Baxter A.J., Jenkins P.D., Jones D.M., Szelke M. Bioorg. Med. Chem. Lett. 6:1996;1163.
21. (a) Cunningham D.F., O'Connor B. Biochem. Biophys. Acta. 1343:1997;160
22. (b) Scanlan M.J., Raj B.K.M., Calvo B., Garin-Chesa P., Sanz-Moncasi M.P., Healey J.H., Old L.J., Rettig W.J. Proc. Nat. Acad. Sci. U.S.A. 91:1994;5657
23. (c) Pineiro-Sanchez M.L., Goldstein L.A., Dodt J., Howard L., Yeh Y., Chen W.-T. J. Biol. Chem. 272:1997;7595.
24. Senten K., der Veken P.V., Bal G., De Meester I., Lambeir A.-M., Scharpe S., Bauvois B., Haemers A., Augustyns K. Bioorg. Med. Chem. Lett. 12:2002;2825.
25. 1H NMR, mass spectrometry, and HPLC analysis. This work was reported in part; Parmee, E.R., 225th National Meeting of the ACS, New Orleans, LA, March 2003; Abstr. 23.
26. 2SO2Cl.
27. (a) For discussion on the relevance of binding to the hERG potassium channel and assay conditions, see: Friesen R.W., Ducharme Y., Ball R.G., Blouin M., Boulet L., Cote B., Frenette R., Girard M., Guay D., Huang Z., Jones T.R., Laliberte F., Lynch J.J., Mancini J., Martins E., Masson P., Muise E., Pon D.J., Siegl P.K.S., Styhler A., Tsou N.N., Turner M.J., Young R.N., Girard Y. J. Med. Chem. 46:2003;2413. and references therein (b) Pearlstein R., Vaz R., Rampe D. J. Med. Chem. 46:2003;2017.
28. (a) For discussion on the relevance of binding to the hERG potassium channel and assay conditions, see: Friesen R.W., Ducharme Y., Ball R.G., Blouin M., Boulet L., Cote B., Frenette R., Girard M., Guay D., Huang Z., Jones T.R., Laliberte F., Lynch J.J., Mancini J., Martins E., Masson P., Muise E., Pon D.J., Siegl P.K.S., Styhler A., Tsou N.N., Turner M.J., Young R.N., Girard Y. J. Med. Chem. 46:2003;2413. and references therein (b) Pearlstein R., Vaz R., Rampe D. J. Med. Chem. 46:2003;2017.